|
Endometrioma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The aim of the present study was to evaluate the effect of medical treatment of ovarian endometriomas on cyst diameter, associated pain, and ovarian reserve as measured with antral follicle count (AFC) and anti-Mullerian hormone (AMH).
|
31304853 |
2020 |
|
Endometrioma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Assessing the ovarian reserve indicators, in the group I patients with recurrent unilateral endometriomas the serum level of AMH was significantly lower (2.1 ± 1.75 vs. 3.2 ± 1.4, <i>p</i> < .005), as well as the number of retrieved oocytes (8.1 ± 3.9 and 10.1 ± 6.8, <i>p</i> < .005).
|
31532313 |
2019 |
|
Endometrioma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A significant difference in the AMH decrease was present between bilateral and monolateral endometriomas (<i>P</i> = .006).
|
30764716 |
2019 |
|
Endometrioma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Since low AMH implies a shorter reproductive lifespan, excision of endometrioma should be cautiously considered, especially in bilateral cases.
|
30715359 |
2019 |
|
Endometrioma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Effects of endometrioma cystectomy on AMH are dependent on characteristics of the endometrioma, showing long-term a decrease in patients with larger, bilateral cysts and in stage IV endometriosis, but only short-time decrease in smaller, unilateral cysts and stage III which sometimes also can fully recover in AMH production within one year.
|
30732484 |
2019 |
|
Endometrioma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
AMH serum levels decreased in both endometriomas and other benign cysts, but significant recovery was reported only in endometriomas (p = .029).
|
29724140 |
2018 |
|
Endometrioma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We aimed to evaluate the impact of topical hemostatic sealants and bipolar coagulation during laparoscopic ovarian endometriotic cyst resection on ovarian reserve by comparing the rates of decrease in anti-Müllerian hormone (AMH).
|
29271052 |
2018 |
|
Endometrioma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Assessing both antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) levels as measures of ovarian reserve, the results suggest that CO2 technology may be an alternative treatment for endometrioma, causing minimal damage to adjacent healthy ovarian tissue.
|
30299482 |
2018 |
|
Endometrioma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The mean AMH level was 42% lower in the endometrioma surgery group than in the endometrioma group and 30% lower in the endometrioma group than in the control group (p = .080 and p = .160, respectively).
|
29258358 |
2018 |
|
Endometrioma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The levels of circulating human epididymis protein 4 (HE4) and carbohydrate antigen 125 (CA125), together with AGCT markers inhibin B and anti-Müllerian hormone (AMH), were measured in 135 samples from AGCT patients, 37 epithelial ovarian carcinoma (EOC) patients, and 40 endometrioma (ENDO) patients.
|
27871721 |
2017 |
|
Endometrioma
|
0.100 |
Biomarker
|
disease |
BEFREE |
AFC vs. AMH: prediction of ovarian response in women with endometrioma undergoing controlled ovarian stimulation.
|
28617534 |
2017 |